Treatment of type 2 diabetes mellitus

被引:35
作者
Feinglos, MN
Bethel, MA
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Endocrinol & Metab, Durham, NC 27710 USA
关键词
D O I
10.1016/S0025-7125(05)70023-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although most patients with type 2 diabetes mellitus can be initially managed with diet and exercise alone, most eventually require at least oral agents if not insulin to maintain glycemic control. Appropriate therapeutic regimens may be difficult to design, given the diversity of drugs available for clinical use. Physicians must consider not only glycemic control, but also patient preference, concomitant medical conditions, and cost when designing therapeutic regimens.
引用
收藏
页码:757 / +
页数:36
相关论文
共 122 条
[1]  
ALBU J, 1995, DIABETES REV, V3, P335
[2]  
*AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS93
[3]  
*AM DIAB ASS, 1997, DIABETES CARE S1, V20, pS14
[4]   Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus [J].
Anderson, JH ;
Brunelle, RL ;
Keohane, P ;
Koivisto, VA ;
Trautmann, ME ;
Vignati, L ;
DiMarchi, R .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1249-1255
[5]   Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes [J].
Anderson, RA ;
Cheng, NZ ;
Bryden, NA ;
Polansky, MM ;
Cheng, NP ;
Chi, JM ;
Feng, JG .
DIABETES, 1997, 46 (11) :1786-1791
[6]  
[Anonymous], 1995, DIABETES CARE, V18, P1510
[7]  
[Anonymous], 1995, Diabetes, V44, P1249
[8]  
[Anonymous], 1995, Br. Med. J, DOI DOI 10.1136/BMJ.310.6972.83
[9]  
Arch JRS, 1996, INT J OBESITY, V20, P191
[10]   BIGUANIDES AND NIDDM [J].
BAILEY, CJ .
DIABETES CARE, 1992, 15 (06) :755-772